The plaintiffs contend that the practices have driven up the wholesale cost of drugs for institutional buyers, including health insurers and government programs such as Medicaid, which in turn has cost taxpayers and insurance buyers billions of dollars.
That in turn has cost taxpayers and insurance buyers billions of dollars. The plaintiffs contended the practices had driven up the wholesale cost of drugs for institutional buyers, including health insurers and government programs such as Medicaid.
The plaintiffs contended the practices had driven up the wholesale cost of drugs for institutional buyers, including health insurers and government programs such as Medicaid. That in turn has cost taxpayers and insurance buyers billions of dollars.
The plaintiffs contended the practices had driven up the wholesale cost of drugs for institutional buyers, including health insurers and government programs such as Medicaid. That in turn has cost taxpayers and insurance buyers billions of dollars.